Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health

• CLAIRITY BREAST provides clinicians with a first-in-class, novel platform for identifying future risk of breast cancer
• A milestone in equitable healthcare, with potentially life-saving insights from a screening mammogram alone
• FDA grants De Novo authorization for new device for future five-year breast cancer risk prediction, based on an image alone

BOSTON & CHICAGO–(BUSINESS WIRE)–#AI—Clairity, Inc., a digital health innovator advancing AI-driven…